Paul J. Diaz, President and Chief Executive Officer: "As we executed strategic initiatives to accelerate growth during the recent stages of the COVID-19 pandemic, we saw a significant recovery in test ...

Tachibana provided third quarter 2025 guidance of total company revenue in the range of $12 million to $14 million and pharma test/services revenue in the range of $11 million to $13 million.

The company raised 2025 total revenue guidance to $310 million–$320 million. Stokes explained that “our normalized revenue growth range in 2025 would be approximately 21% to 26%” when excluding ...

CEO Guillaume Marie Jean Rutten reported second quarter revenue of $1.51 billion, a 14% sequential increase, stating "all end markets showing double-digit sequential growth." Rutten highlighted that ...

Net sales were a record $22.3 million, up from $20.3 million in the fourth quarter of fiscal 2022. GAAP net income was a record $6.1 million, or $0.21 per diluted share, up from GAAP net income of ...

Sales of new productions and developments came in at €2.0 million, down sharply due to the halt in order from international streaming platforms, as well as the low level of deliveries for proprietary ...

Have you assessed how the international operations of Coca-Cola (KO) performed in the quarter ended March 2024? For this world's largest beverage maker, possessing an expansive global footprint, ...

Lee Enterprises reported a 5% increase in total digital revenue and a 14% rise in digital-only subscriptions for Q1 2025. Lee Enterprises, Incorporated has reported a 5% year-over-year increase in ...

What is 23andMe+ Total Health? 23andMe+ Total Health is a new annual membership that expands on the 23andMe DNA test to include comprehensive blood tests and health screenings. The brand says the ...